Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06393361
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2024-04-28
Brief Title:
ChidamideDecitabine Plus Anti-PD-1 Antibody for Patients With RR cHL Who Are Transplant-ineligible or Refused Transplant
Sponsor:
Organization:
Chinese PLA General Hospital